Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ACAR, Jacques F")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44

  • Page / 2
Export

Selection :

  • and

A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human floraACAR, Jacques F.Chemotherapy (Basel). 2001, Vol 47, pp 15-23, issn 0009-3157, SUP3Conference Paper

Resistance mechanismsACAR, Jacques F.Seminars in respiratory infections. 2002, Vol 17, Num 3, pp 184-188, issn 0882-0546Article

New strategies in infectious diseases: rationale for the use of novel spreptogramins: a seminar-in-printACAR, Jacques F; ANDRIOLE, Vincent T.Drugs (Basel). 1996, Vol 51, issn 0012-6667, 49 p., SUP1Serial Issue

Sulbactam: worldwide clinical experience, a symposium, Istanbul, July 21, 1987BLUESTONE, Charles D; ACAR, Jacques F.APMIS. Acta pathologica, microbiologica et immunologica scandinavica. 1989, Vol 97, 69 p.Conference Proceedings

Antibiotic synergy and antagonismACAR, Jacques F.The Medical clinics of North America. 2000, Vol 84, Num 6, issn 0025-7125, v,1391-1406 [17 p.]Article

Third-generation cephalosporins : a decade of progress in the treatment of severe infectious, June 13, 1989NEU, HAROLD C; RUBINSTEIN, ETHAN; ACAR, JACQUES F et al.The American journal of medicine. 1990, Vol 88, issn 0002-9343, 47 p., suppl. 4AConference Proceedings

Streptogramins : A unique class of antibioticsPECHERE, J.-C.Drugs (Basel). 1996, Vol 51, pp 13-19, issn 0012-6667, SUP1Article

Mechanism of action of streptogramins and macrolidesVANNUFFEL, P; COCITO, C.Drugs (Basel). 1996, Vol 51, pp 20-30, issn 0012-6667, SUP1Article

Future prospects and therapeutic potential of streptograminsRUBINSTEIN, E; KELLER, N.Drugs (Basel). 1996, Vol 51, pp 38-42, issn 0012-6667, SUP1Article

Antibacterial activity of quinupristin/dalfopristin : Rationale for clinical useFINCH, R. G.Drugs (Basel). 1996, Vol 51, pp 31-37, issn 0012-6667, SUP1Article

Empiric therapy of severe infections in adultsMODAI, J.The American journal of medicine. 1990, Vol 88, pp 4A.12S-4A.17S, issn 0002-9343, suppl. 4AConference Paper

How to modify conditions limiting resistance in bacteria in animals and other reservoirsHELMUTH, R; PROTZ, D.Clinical infectious diseases. 1997, Vol 24, pp S136-S138, issn 1058-4838, SUP1Conference Paper

Increases in rates of resistance to trimethoprimHUOVINEN, P.Clinical infectious diseases. 1997, Vol 24, pp S63-S66, issn 1058-4838, SUP1Conference Paper

Antibiotic resistance in Neisseria meningitidisOPPENHEIM, B. A.Clinical infectious diseases. 1997, Vol 24, pp S98-S101, issn 1058-4838, SUP1Conference Paper

Enterococci acquire new kinds of resistanceLECLERCQ, R.Clinical infectious diseases. 1997, Vol 24, pp S80-S84, issn 1058-4838, SUP1Conference Paper

The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locallyO'BRIEN, T. F.Clinical infectious diseases. 1997, Vol 24, pp S2-S8, issn 1058-4838, SUP1Conference Paper

Perspectives on chemotherapeutic approaches to antibiotic-resistant bacteriaKESSLER, R. E.Clinical infectious diseases. 1997, Vol 24, pp S146-S147, issn 1058-4838, SUP1Conference Paper

Recent evaluation of antimicrobial resistance in β-hemolytic streptococciKAPLAN, E. L.Clinical infectious diseases. 1997, Vol 24, pp S89-S92, issn 1058-4838, SUP1Conference Paper

Strategies for the rational use of antimicrobialsCOUPER, M. R.Clinical infectious diseases. 1997, Vol 24, pp S154-S156, issn 1058-4838, SUP1Conference Paper

Antibiotic resistance : A view from the pharmaceutical industryBAX, R. P.Clinical infectious diseases. 1997, Vol 24, pp S151-S153, issn 1058-4838, SUP1Conference Paper

Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibioticsMEDEIROS, A. A.Clinical infectious diseases. 1997, Vol 24, pp S19-S45, issn 1058-4838, SUP1Conference Paper

Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. WHO SymposiumACAR, Jacques F; KAPLAN, Edward L; O'BRIEN, Thomas F et al.Clinical infectious diseases. 1997, Vol 24, issn 1058-4838, 180 p., SUP1Conference Proceedings

Consequences of bacterial resistance to antibiotics in medical practiceACAR, J. F.Clinical infectious diseases. 1997, Vol 24, pp S17-S18, issn 1058-4838, SUP1Conference Paper

Antibiotic resistance in Streptococcus pneumoniaeTOMASZ, A.Clinical infectious diseases. 1997, Vol 24, pp S85-S88, issn 1058-4838, SUP1Conference Paper

Antimicrobial resistance in Neisseria gonorrhoeaeLIND, I.Clinical infectious diseases. 1997, Vol 24, pp S93-S97, issn 1058-4838, SUP1Conference Paper

  • Page / 2